Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1All patients in the study will be treated with ocrelizumab
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
2Continued Ocrelizumab
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
3OCRELIZUMAB
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬3件: 13, 46, 49
4Ocrelizumab (CinnaGen, Iran)
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
5Ocrelizumab (Roche, Switzerland)
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
6Ocrelizumab / rhuMAb 2H7
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
7Ocrelizumab 300 mg
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
8Ocrelizumab 300mg
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
9Ocrelizumab 300mg /10ml
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
10Ocrelizumab 300mg/10 ml
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
11Ocrelizumab 300mg/10ml
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
12Ocrelizumab 500mg
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
13Ocrelizumab 600 mg
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
14Ocrelizumab at home
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
15Ocrelizumab Dose 1
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
16Ocrelizumab Dose 2 and Dose 3
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
17Ocrelizumab IV
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
18Ocrelizumab SC
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
19Other: Observation of Ocrelizumab as Treatment in RRMS Patients
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
20Other: Ocrelizumab
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
21Short-course Ocrelizumab
(Synonym: D05218)
1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13